Allogeneic Transplantation From Related Haploidentical Donors

NCT00185692 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Blood Cancer
Leukemia
Graft Versus Host Disease
Malignancy
CLL
NHL
Hodgkin's Disease
MDS

Interventions

PROCEDURE: non-myeloablative hematopoietic cell transplantation
DRUG: Anti-Thymocyte Globulin
DRUG: Cyclosporine
DRUG: Mycophenolate Mofetil
DRUG: G-CSF
DRUG: Solumedrol
DRUG: Acetaminophen
DRUG: Diphenydramine
DRUG: Hydrocortisone

Sponsor

Stanford University